agilon health, inc. (NYSE:AGL) Short Interest Update

agilon health, inc. (NYSE:AGL - Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 31,940,000 shares, an increase of 5.1% from the November 15th total of 30,390,000 shares. Based on an average daily volume of 4,590,000 shares, the short-interest ratio is presently 7.0 days. Currently, 10.5% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on AGL. Royal Bank of Canada reiterated an "outperform" rating and issued a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Citigroup cut their price objective on agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a research note on Wednesday, November 13th. Stifel Nicolaus decreased their target price on agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a research report on Tuesday, November 12th. JMP Securities cut agilon health from an "outperform" rating to a "market perform" rating in a research report on Monday, November 11th. Finally, Macquarie initiated coverage on agilon health in a research note on Monday. They issued a "neutral" rating and a $3.00 price objective for the company. Three research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $4.28.

agilon health Stock Down 2.2 %

Shares of NYSE AGL traded down $0.05 during mid-day trading on Monday, hitting $2.19. The company had a trading volume of 5,988,980 shares, compared to its average volume of 4,861,157. agilon health has a 1-year low of $1.50 and a 1-year high of $13.45. The company has a market capitalization of $902.32 million, a PE ratio of -2.38 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The business's 50-day simple moving average is $2.44 and its 200 day simple moving average is $4.38.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter in the previous year, the business posted ($0.06) EPS. On average, analysts predict that agilon health will post -0.52 earnings per share for the current year.

Insider Activity at agilon health

In other agilon health news, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The stock was acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now directly owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the firm's stock in a transaction dated Monday, November 25th. The shares were acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 90,000 shares of company stock worth $198,100 in the last three months. Company insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. CWM LLC increased its stake in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC purchased a new stake in agilon health in the second quarter valued at $60,000. Neo Ivy Capital Management purchased a new position in shares of agilon health during the second quarter worth about $1,006,000. Pallas Capital Advisors LLC purchased a new position in shares of agilon health during the second quarter worth about $77,000. Finally, Bank of New York Mellon Corp increased its position in shares of agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company's stock worth $7,252,000 after purchasing an additional 174,883 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.